Xcout Intel
Cyrus Biotechnology, Inc.
Cyrus Biotechnology, Inc. is a biotechnology company with a corporate office located on 2nd Avenue in Seattle, Washington, United States. The firm provides advanced computational biology software and services.
Subscribe to see Cyrus Biotechnology, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cyrus Biotechnology, Inc. at a glance
Cyrus Biotechnology, Inc. is a drug discovery company headquartered in United States. Its most recent funding round raised $1.5M in July 2025. Xcout tracks 7 named people at Cyrus Biotechnology, Inc., including Lucas Nivon (Chief Executive Officer).
Cyrus Biotechnology, Inc. leadership
- Lucas NivonChief Executive Officer
- Mark BenjaminExecutive Officer
- Anthony ManningDirector
- Chad WaiteDirector
- Jason SmithDirector
- Ramakrishna SatyavoluDirector
1 more named person on record for Cyrus Biotechnology, Inc., with roles, board committees and tenure — see the full roster →
Cyrus Biotechnology, Inc. funding rounds
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.5M | — | |
| SEC Form D filing | $3.2M | — | |
| SEC Form D filing | $2.7M | — | |
| Series A | $18M | — | |
| SEC Form D filing | $1.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Cyrus Biotechnology, Inc. competitors
A few of Cyrus Biotechnology, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Pharmacelera is a computational chemistry company based in Barcelona, Spain, that provides drug discovery services and solutions for biotech and pharmaceutical clients.
Immusoft Corp. is based in Seattle, Washington, and operates as a corporate entity engaged in technical research and business operations.
Good Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington. The firm focuses on drug discovery and the development of novel therapeutic pipelines and biopharmaceuticals.
CytoDel, Inc. is a biopharmaceutical firm that produces recombinant botulinum neurotoxin derivatives and utilizes neurotoxins as molecular vehicles for intraneuronal drug delivery.
Get Cyrus Biotechnology, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cyrus Biotechnology, Inc. in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 10 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access